The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major ...
The U.S. Food and Drug Administration has approved the expanded use of Axsome Therapeutics' Auvelity (dextromethorphan ...
Agitation in dementia is often caused by brain changes and can worsen over time. Familiar routines and avoiding known triggers can help manage agitation. Caregivers should use nondrug strategies ...
Auvelity was initially approved by the FDA to treat major depressive disorder.
While most people are familiar with Alzheimer’s disease, a progressive neurological disorder and the most common cause of dementia, it is often difficult to truly understand the common symptoms and ...
Agitation is a neuropsychiatric symptom in patients with Alzheimer's disease (AD), the most common form of dementia. The prevalence of this symptom is about 40%-65% ...
Please provide your email address to receive an email when new articles are posted on . Researchers reviewed 18 randomized clinical trials that recruited individuals with dementia and ...
Combative and agitated behavior in people with dementia is not rare. Managing this behavior is difficult. Research is limited but cannabis may be of help. The concepts of cannabis use in our society ...
Approximately 6.5 million Americans and their loved ones, friends, and caregivers experience the distress associated with Alzheimer’s dementia. One of the most troubling symptoms associated with this ...
Scientists have found a link between anxiety and dementia risk. Eloisa Ramos/Stocksy Past studies have also found a connection between anxiety and an increased risk for dementia. Now, researchers from ...
In the realm of medical care for individuals grappling with dementia, a fundamental aspect crucial for both health care professionals and caregivers is understanding the terminologies that define the ...
Please provide your email address to receive an email when new articles are posted on . Patients with chronic anxiety and new anxiety were approximately three times more likely to develop dementia.